Dr. Tejus Pradeep, MD

Dr. Pradeep practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Pradeep's NPI, 1053828855, was assigned on January 3, 2018. Dr. Pradeep graduated from The Johns Hopkins University School of Medicine in 2020. Dr. Pradeep holds Florida license ME167188.

Dr. Pradeep's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Pradeep's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Pradeep to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pradeep practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Pradeep's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Pradeep is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pradeep's licenses on file in 2 states: Florida and Pennsylvania.

CMS data shows 12 Medicare services from Dr. Pradeep across 1 procedure code in 2024, for 31 Medicare patients. Medicare paid $1,179 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Pradeep in 2024. The largest group is 65 to 74, with 14 patients. 74% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pradeep's median patient age at 72, with 58% women.

In 2024, Dr. Pradeep wrote 263 Medicare Part D claims for 150 patients. 78% of them were for generic drugs. CMS names the drug for 201 of them, across 5 drugs with 11 or more claims each, at $3,651 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Pradeep for performance year 2024, reported as part of a group. Dr. Pradeep accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Pradeep, published from 2018 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Antibodies, Monoclonal, Humanized, Graves Ophthalmopathy and United States Food and Drug Administration. Dr. Pradeep has published most often in Int J Dermatol. Dr. Pradeep's most frequent co-authors are Matthew Mao Zhang, MD, Scott A. Elman, MD and Michael Johnathan Charles Bray, MS.

CMS Open Payments shows 4 general payments to Dr. Pradeep from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Glaukos Corporation paid the most, $149.

Dr. Pradeep graduated from The Johns Hopkins University School of Medicine in 2020.

Dr. Pradeep is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.